Atea Pharmaceuticals (AVIR) Shares Outstanding (2020 - 2022)
Historic Shares Outstanding for Atea Pharmaceuticals (AVIR) over the last 3 years, with Q3 2022 value amounting to $83.3 million.
- Atea Pharmaceuticals' Shares Outstanding rose 28.97% to $83.3 million in Q3 2022 from the same period last year, while for Sep 2022 it was $83.3 million, marking a year-over-year increase of 28.97%. This contributed to the annual value of $83.1 million for FY2021, which is 80.76% up from last year.
- Per Atea Pharmaceuticals' latest filing, its Shares Outstanding stood at $83.3 million for Q3 2022, which was up 28.97% from $83.3 million recorded in Q2 2022.
- Atea Pharmaceuticals' Shares Outstanding's 5-year high stood at $83.3 million during Q3 2022, with a 5-year trough of $10.1 million in Q1 2020.
- For the 3-year period, Atea Pharmaceuticals' Shares Outstanding averaged around $63.1 million, with its median value being $82.8 million (2021).
- In the last 5 years, Atea Pharmaceuticals' Shares Outstanding surged by 72144.74% in 2021 and then increased by 28.97% in 2022.
- Over the past 3 years, Atea Pharmaceuticals' Shares Outstanding (Quarter) stood at $82.4 million in 2020, then increased by 0.81% to $83.1 million in 2021, then increased by 0.22% to $83.3 million in 2022.
- Its last three reported values are $83.3 million in Q3 2022, $83.3 million for Q2 2022, and $83.3 million during Q1 2022.